Holen Sie sich die Stockscreener-App
0.5291
14.13%
0.0655
Handel nachbörslich:
.90
0.3709
+70.10%
Schlusskurs vom Vortag:
$0.4636
Offen:
$0.469
24-Stunden-Volumen:
533.85K
Relative Volume:
0.12
Marktkapitalisierung:
$3.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.89M
KGV:
-0.0253
EPS:
-20.8847
Netto-Cashflow:
$-16.44M
1W Leistung:
+46.97%
1M Leistung:
+36.93%
6M Leistung:
-85.66%
1J Leistung:
-90.64%
1-Tages-Spanne:
$0.44
$0.5495
1-Wochen-Bereich:
$0.3197
$0.5495
52-Wochen-Spanne:
$0.2907
$14.14
Glucotrack Inc Stock (GCTK) Company Profile
Firmenname
Glucotrack Inc
Sektor
Telefon
972 (8) 675-7878
Adresse
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.5291 | 2.90M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
379.50 | 144.19B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
150.65 | 42.39B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.66 | 34.31B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
66.86 | 33.65B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
193.01 | 28.79B | 5.54B | 1.52B | 1.74B | 10.37 |
Glucotrack Inc Aktie (GCTK) Neueste Nachrichten
Glucotrack and Lōkahi Therapeutics Complete Strategic - GlobeNewswire
After Lōkahi Deal, Glucotrack’s Glucose Tech Will Run Separately - Stock Titan
GlucoTrack Inc (NASDAQ: GCTK) Stock Price, News & Analysis - Kalkine
Glucotrack expands IP to cover novel glucose monitor sensor architectures - Drug Delivery Business
Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM - Yahoo Finance
Glucotrack Issued Notice of Allowance by USPTO for Patent Application Covering Implantable CBGM Platform - citybiz
Glucotrack receives patent allowance for glucose monitoring system - Investing.com
GlucoTrack Issued US Patent Office Allowance for Blood Glucose Monitoring System - marketscreener.com
Glucotrack receives patent allowance for glucose monitoring system By Investing.com - Investing.com Canada
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform - The Manila Times
Glucotrack Announces USPTO Notice Of Allowance For Patent Application Covering Its Implantable CBGM Platform - Menafn
Glucotrack patent wins USPTO notice as implantable glucose monitor advances - Stock Titan
GlucoTrack Inc. (GCTK) Holds Near Support Despite Modest DeclineLarge Cap Trends - DonanımHaber
GlucoTrack Stock Declines 5% as Shares Test Key Support at $0.31Volume Breakout Ideas - dars.gov.et
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Price to sales forward of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView
Price to book forward of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView
GlucoTrack Inc (GCTK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GlucoTrack Inc (GCTK) Institutional Confidence - TradingKey
GlucoTrack Inc (GCTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GlucoTrack Inc (GCTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GlucoTrack Inc (GCTK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GlucoTrack Inc (GCTK) Valuation: PE, PB & Fair Value Analysis - TradingKey
GlucoTrack Inc (GCTK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
GlucoTrack Inc (GCTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Glucotrack (NASDAQ: GCTK) seeks reverse split, warrant repricing and auditor ratification - Stock Titan
EBIT per share of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAditxt Inc Ordinary Shares (NASDAQ:ADTX) - Benzinga
GLUCOTRACK INC (GCTK) Stock Chart - ChartMill
GCTK Stock Price, Quote & Chart | GLUCOTRACK INC (NASDAQ:GCTK) - ChartMill
Glucotrack CEO explains tech behind long-term CBGM implant - Drug Delivery Business
GCTKGlucoTrack Inc Short Interest - Finviz
Glucotrack Inc Highlights Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association 2026 Scientific Sessions - marketscreener.com
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions - The Manila Times
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions - Moomoo
Implantable glucose sensor designed for multi-year use without wearables - Stock Titan
GlucoTrack Inc. (GCTK) Surges 8%: Testing Key Resistance at $0.53PCR Spike - The Legal Advocate
GlucoTrack Inc. (GCTK) Rallies 8.23% as Shares Test Key Resistance LevelBlock Trade Flow - thelegaladvocate.com
GlucoTrack Inc. (GCTK) Rebounds Sharply: Bullish Momentum Building Above SupportContinuation Pattern Picks - The Legal Advocate
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
GlucoTrack Faces Multiple Nasdaq Deficiency Notices, Delisting Risk - TipRanks
Glucotrack receives Nasdaq delisting notice over listing rule deficiencies By Investing.com - Investing.com South Africa
Glucotrack receives Nasdaq delisting notice over listing rule deficiencies - Investing.com
Glucotrack Received Notice of Delisting - TradingView
Glucotrack (GCTK) cited for bid price and equity Nasdaq deficiencies - Stock Titan
Armistice Capital (GCTK) reports 102,115 shares, 4.99% ownership - Stock Titan
Glucotrack Reports Q1 2026 Results and Advances IDE Submission for Implantable Glucose Monitor - Minichart
Glucotrack's 3-Year CGM Aims to Revolutionize Diabetes Management - BriefGlance
Finanzdaten der Glucotrack Inc-Aktie (GCTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):